Pharmacovigilance using clinical notes

Clinical Pharmacology and Therapeutics

Volumn 93, Issue 6, 2013, Pages 547-555

  LePendu, P ^a   Iyer, S V ^a   Bauer Mehren, A ^a   Harpaz, R ^a   Mortensen, J M ^a   Podchiyska, T ^b   Ferris, T A ^b   Shah, N H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ALLOPURINOL; ANASTROZOLE; CABERGOLINE; CELECOXIB; CERIVASTATIN; CISAPRIDE; CLOPIDOGREL; CLOZAPINE; DROSPIRENONE; FLUDARABINE; LEVONORGESTREL; MEDROXYPROGESTERONE; PERGOLIDE; PHENOBARBITAL; PHENTERMINE; PIOGLITAZONE; RALOXIFENE; RITUXIMAB; ROFECOXIB; ROSIGLITAZONE; SIBUTRAMINE; TICLOPIDINE; TROGLITAZONE; VALDECOXIB; VALPROIC ACID;

ACUTE KIDNEY FAILURE; ADVERSE OUTCOME; APLASTIC ANEMIA; ARTICLE; BLADDER CANCER; DRUG INFORMATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ELECTRONIC MEDICAL RECORD; HEART INFARCTION; HEART MUSCLE FIBROSIS; HUMAN; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; QT PROLONGATION; RHABDOMYOLYSIS; VEIN THROMBOSIS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATA MINING; DRUG INTERACTIONS; DRUG TOXICITY; ELECTRONIC HEALTH RECORDS; HUMANS; PHARMACOVIGILANCE; PREVALENCE; UNITED STATES;

EID: 84878253500     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.47     Document Type: Article

References (50)

1. Classen, D.C. et al. 'Global trigger tool' shows that adverse events in hospitals may be ten times greater than previously measured. Health Af. (Millwood). 30, 581-589 (2011).
2. Hug, B.L., Keohane, C., Seger, D.L., Yoon, C. & Bates, D.W. The costs of adverse drug events in community hospitals. Jt. Comm. J. Qual. Patient Saf. 38, 120-126 (2012).
3. Bushardt, R.L., Massey, E.B., Simpson, T.W., Ariail, J.C. & Simpson, K.N. Poly-pharmacy: misleading, but manageable. Clin. Interv. Aging 3, 383-389 (2008).
4. Stang, P.E. et al. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann. Intern. Med. 153, 600-606 (2010).
5. Friedman, C.P., Wong, A.K. & Blumenthal, D. Achieving a nationwide learning health system. Sci. Transl. Med. 2 (57), 57cm29 (2010).
6. McClellan, M. Drug safety reform at the FDA-pendulum swing or systematic improvement? N. Engl. J. Med. 356, 1700-1702 (2007).
7. Avorn, J. & Schneeweiss, S. Managing drug-risk information-what to do with all those new numbers. N. Engl. J. Med. 361, 647-649 (2009).
8. Gagne, J.J. et al. Active safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring system. Clin. Pharmacol. Ther. 92, 80-86 (2012).
9. Schneeweiss, S., Rassen, J.A., Glynn, R.J., Avorn, J., Mogun, H. & Brookhart, M.A. High-dimensional propensity score adjustment in studies of treatment efects using health care claims data. Epidemiology 20, 512-522 (2009).
10. Coloma, P.M. et al. Electronic healthcare databases for active drug safety surveillance: is there enough leverage? Pharmacoepidemiol. Drug Saf. 21, 611-621 (2012).
11. Melton, G.B. & Hripcsak, G. Automated detection of adverse events using natural language processing of discharge summaries. J. Am. Med. Inform. Assoc. 12, 448-457 (2005).
12. Wang, X., Hripcsak, G., Markatou, M. & Friedman, C. Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study. J. Am. Med. Inform. Assoc. 16, 328-337 (2009).
13. Hennessy, S. & Flockhart, D.A. The need for translational research on drug-drug interactions. Clin. Pharmacol. Ther. 91, 771-773 (2012).
14. Harpaz, R., DuMouchel, W., Shah, N.H., Madigan, D., Ryan, P. & Friedman, C. Novel data-mining methodologies for adverse drug event discovery and analysis. Clin. Pharmacol. Ther. 91, 1010-1021 (2012).
15. Nadkarni, P.M. Drug safety surveillance using de-identifed EMR and claims data: issues and challenges. J. Am. Med. Inform. Assoc. 17, 671-674 (2010).
16. Chapman, W.W., Nadkarni, P.M., Hirschman, L., D'Avolio, L.W., Savova, G.K. & Uzuner, O. Overcoming barriers to NLP for clinical text: the role of shared tasks and the need for additional creative solutions. J. Am. Med. Inform. Assoc. 18, 540-543 (2011).
17. Radecki, R.P. & Sittig, D.F. Application of electronic health records to the Joint Commission's 2011 National Patient Safety Goals. JAMA 306, 92-93 (2011).
18. Morrison, F.P., Li, L., Lai, A.M. & Hripcsak, G. Repurposing the clinical record: can an existing natural language processing system de-identify clinical notes? J. Am. Med. Inform. Assoc. 16, 37-39 (2009).
19. Graham, D.J. et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-infammatory drugs: nested case-control study. Lancet 365, 475-481 (2005).
20. Brownstein, J.S., Sordo, M., Kohane, I.S. & Mandl, K.D. The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction. PLoS ONE 2, e840 (2007).
21. Lependu, P., Iyer, S.V., Fairon, C. & Shah, N.H. Annotation analysis for testing drug safety signals using unstructured clinical notes. J. Biomed. Semantics 3 (suppl. 1), S5 (2012).
22. Ryan, P.B., Madigan, D., Stang, P.E., Overhage, J.M., Racoosin, J.A. & Hartzema, A.G. Empirical assessment of methods for risk identifcation in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership. Stat. Med. 31, 4401-4415 (2012).
23. Phansalkar, S. et al. Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records. J. Am. Med. Inform. Assoc. (2012); e-pub ahead of print 25 September 2012.
24. Halevy, A., Norvig, P. & Pereira, F. The unreasonable efectiveness of data. Intelligent Systems, IEEE 24 (2):8-12 (2009).
25. Domingos, P. A few useful things to know about machine learning. Commun. ACM. 55 (10):78-87 (2012).
26. Bate, A. & Evans, S.J. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol. Drug Saf. 18, 427-436 (2009).
27. Aronson, A.R. & Lang, F.M. An overview of MetaMap: historical perspective and recent advances. J. Am. Med. Inform. Assoc. 17, 229-236 (2010).
28. D'Avolio, L.W., Nguyen, T.M., Goryachev, S. & Fiore, L.D. Automated concept-level information extraction to reduce the need for custom software and rules development. J. Am. Med. Inform. Assoc. 18, 607-613 (2011).
29. Savova, G.K. et al. Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications. J. Am. Med. Inform. Assoc. 17, 507-513 (2010).
30. LePendu, P., Liu, Y., Iyer, S., Udell, M. & Shah, N.H. Analyzing patterns of drug use in clinical notes for patient safety. AMIA Summit on Clinical Research Informatics, San Francisco, CA, 21-23 March 2012.
31. Liu, Y., LePendu, P., Iyer, S., Udell, M. & Shah, N.H. Using temporal patterns in medical records to discern adverse drug events from indications. AMIA Summit on Clinical Research Informatics, San Francisco, CA, 21-23 March 2012.
32. Schuemie, M.J. et al. Using electronic health care records for drug safety signal detection: a comparative evaluation of statistical methods. Med. Care 50, 890-897 (2012).
33. Hauben, M. & Bate, A. Decision support methods for the detection of adverse events in post-marketing data. Drug Discov. Today 14, 343-357 (2009).
34. Lowe, H.J., Ferris, T.A., Hernandez, P.M. & Weber, S.C. STRIDE-an integrated standards-based translational research informatics platform. AMIA Annu. Symp. Proc. 2009, 391-395 (2009).
35. Trifrò, G. et al.; EU-ADR group. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Pharmacoepidemiol. Drug Saf. 18, 1176-1184 (2009).
36. OMOP. Detection of Long Term Adverse Drug Reactions in Electronic Health Data, 2012; 〈http://omop.fnih.org/sites/default/fles/Schuemie- Detection%20of%20ADRs-Protocol%202011.pdf〉 (2012).
37. Bauer-Mehren, A. et al. Automatic fltering and substantiation of drug safety signals. PLoS Comput. Biol. 8, e1002457 (2012).
38. Kuhn, M., Campillos, M., Letunic, I., Jensen, L.J. & Bork, P. A side efect resource to capture phenotypic efects of drugs. Mol. Syst. Biol. 6, 343 (2010).
39. Hanauer, D.A. & Ramakrishnan, N. Modeling temporal relationships in large scale clinical associations. J. Am. Med. Inform. Assoc. 20, 332-341 (2012).
40. Sekhon, J.S. Multivariate and propensity score matching software with automated balance optimization: the matching package for R. J. Stat. Softw. 42 (7), 1-52 (2011).
41. Shah, N.H., Bhatia, N., Jonquet, C., Rubin, D., Chiang, A.P. & Musen, M.A. Comparison of concept recognizers for building the Open Biomedical Annotator. BMC Bioinformatics 10 (suppl. 9), S14 (2009).
42. Harkema, H., Dowling, J.N., Thornblade, T. & Chapman, W.W. ConText: an algorithm for determining negation, experiencer, and temporal status from clinical reports. J. Biomed. Inform. 42, 839-851 (2009).
43. Paumier, S. De la reconnaissance de formes linguistiques à l'analyse syntaxique, Université de Marne-la-Vallée (2003).
44. Demner-Fushman, D., Mork, J.G., Shooshan, S.E. & Aronson, A.R. UMLS content views appropriate for NLP processing of the biomedical literature vs. clinical text. J. Biomed. Inform. 43, 587-594 (2010).
45. McCray, A.T., Bodenreider, O., Malley, J.D. & Browne, A.C. Evaluating UMLS strings for natural language processing. Proc. AMIA Symp., 448-452 (2001).
46. Xu, R., Musen, M.A. & Shah, N.H. A comprehensive analysis of fve million UMLS metathesaurus terms using eighteen million MEDLINE citations. AMIA Annu. Symp. Proc. 2010, 907-911 (2010).
47. Wu, S.T. et al. UMLS term occurrences in clinical notes: a large scale corpus analysis. JAMIA 19, e149-e156 (2012).
48. Bodenreider, O. & McCray, A.T. Exploring semantic groups through visual approaches. J. Biomed. Inform. 36, 414-432 (2003).
49. Uzuner, O. Recognizing obesity and comorbidities in sparse data. J. Am. Med. Inform. Assoc. 16 (4), 561-570 (2009).
50. Marshall, M.S. et al. Emerging practices for mapping and linking life sciences data using RDF-a case series. Web Semantics: Science, Services and Agents on the World Wide Web 14, 2-13 (2012).